|
Volumn 348, Issue 19, 2003, Pages 1920-1925
|
Smallpox and smallpox vaccination [1] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
CIDOFOVIR;
METISAZONE;
SMALLPOX VACCINE;
THIOSEMICARBAZONE;
VIDARABINE;
ANTIVIRUS AGENT;
BIOLOGICAL WARFARE;
HEALTH CARE POLICY;
HOSPITAL INFECTION;
HUMAN;
INFECTION PREVENTION;
INFECTION RATE;
INFECTION RISK;
KIDNEY FAILURE;
LETTER;
METABOLIC ACIDOSIS;
NAUSEA;
NEUTROPENIA;
PRIORITY JOURNAL;
RASH;
SMALLPOX;
UVEITIS;
VACCINATION;
VIRUS SURVIVAL;
VIRUS TRANSMISSION;
VOMITING;
NOTE;
VACCINIA;
AIR;
DISEASE TRANSMISSION;
GROWTH, DEVELOPMENT AND AGING;
PATHOGENICITY;
SMALLPOX VIRUS;
EPIDEMIC;
BIOLOGICAL MODEL;
MORTALITY;
TIME;
ANTIVIRAL AGENTS;
HUMANS;
SMALLPOX;
SMALLPOX VACCINE;
VACCINIA;
VIDARABINE;
AIR;
DISEASE TRANSMISSION, HORIZONTAL;
VARIOLA VIRUS;
BIOTERRORISM;
DISEASE OUTBREAKS;
MODELS, BIOLOGICAL;
TIME FACTORS;
|
EID: 0242720795
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200305083481914 Document Type: Letter |
Times cited : (8)
|
References (0)
|